<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0030">
 <label>30</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Su</surname>
    <given-names>HX</given-names>
   </string-name>, 
   <string-name>
    <surname>Yao</surname>
    <given-names>S</given-names>
   </string-name>, 
   <string-name>
    <surname>Zhao</surname>
    <given-names>WF</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients</article-title>. 
  <source>Acta Pharmacol Sin</source>
  <year>2020</year>;
  <volume>41</volume>:
  <fpage>1167</fpage>–
  <lpage>77</lpage>.
  <pub-id pub-id-type="pmid">32737471</pub-id>
 </mixed-citation>
</ref>
